|
Ris-Rez Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since May 2026
Pipeline
Phase 1: 1Phase 3: 1
Top Sponsors
- GlaxoSmithKline2
Indications
- Cancer2
- Neoplasms, Lung1
- Neoplasms1
- Lung Cancer1
Other1 trial
Stanford, California1 trial
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
GSK Investigational Site
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.